Combinatorial expression of GPCR isoforms affects signalling and drug responses.
Combinatorial expression of GPCR isoforms affects signalling and drug responses.
复制标题
DOI:
10.1038/s41586-020-2888-2
复制
发表时间:
2020-11
期刊:
影响因子:
64.8
通讯作者:
Babu MM
中科院分区:
文献类型:
--
作者:
Marti-Solano M;Crilly SE;Malinverni D;Munk C;Harris M;Pearce A;Quon T;Mackenzie AE;Wang X;Peng J;Tobin AB;Ladds G;Milligan G;Gloriam DE;Puthenveedu MA;Babu MM
G protein-coupled receptors (GPCRs) are transmembrane proteins that modulate physiology across diverse tissues in response to extracellular signals. GPCR signalling can differ due to variation in the sequence (e.g. polymorphisms) or in the expression of receptors in different tissues. The resulting differences in response are an important source of physiological signalling bias. An underexplored source of such bias is the generation of functionally diverse GPCR isoforms that can have distinct patterns of expression in human tissues. Here, we report the findings from a comprehensive study, integrating data from human tissue-level transcriptomes, GPCR sequences and structures, functional annotations, proteomics, single-cell RNA sequencing, population-wide genetic association studies, and pharmacological experiments. Our results show how a single GPCR gene can diversify into multiple isoforms with distinct structural and signalling properties, and how unique combinations of these isoforms can be expressed in different human tissues, contributing to differences in physiological signalling. Based on their structural changes and expression patterns, some of the detected isoforms may also influence drug response and represent new drug targets with improved tissue selectivity. Our findings highlight the need to move from a canonical to a context-specific view of GPCR signalling, in which one considers how the combinatorial expression of receptor isoforms in a specific system (i.e. a particular cell type, tissue, or organism) collectively impacts receptor signalling. These observations pave the way for understanding the impact of isoform variation on GPCR signalling response and have implications for exploiting such variation as a source of GPCR selectivity in drug development.
登录
查看更多内容
影响因子:
4.6
作者:
Knierim, Alexander Bernd;Roethe, Juliane;Schoeneberg, Torsten
通讯作者:
Schoeneberg, Torsten
影响因子:
64.5
作者:
Enge M;Arda HE;Mignardi M;Beausang J;Bottino R;Kim SK;Quake SR
通讯作者:
Quake SR
影响因子:
64.5
作者:
Hauser AS;Chavali S;Masuho I;Jahn LJ;Martemyanov KA;Gloriam DE;Babu MM
通讯作者:
Babu MM
影响因子:
16.2
作者:
Bai, Bing;Wang, Xusheng;Peng, Junmin
通讯作者:
Peng, Junmin
影响因子:
3.4
作者:
Eng, Jimmy K.;Jahan, Tahmina A.;Hoopmann, Michael R.
通讯作者:
Hoopmann, Michael R.